tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
aTyr Pharma Inc options imply 21.3% move in share price post-earnings
PremiumThe FlyaTyr Pharma Inc options imply 21.3% move in share price post-earnings
3M ago
ATYR Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
ATYR Earnings this Week: How Will it Perform?
4M ago
Atyr Pharma’s Promising Study on Efzofitimod for SSc-ILD: Key Insights for Investors
Premium
Company Announcements
Atyr Pharma’s Promising Study on Efzofitimod for SSc-ILD: Key Insights for Investors
4M ago
Cautious Hold Rating for aTyr Pharma Amid Mixed Clinical Trial Results and Regulatory Uncertainty
PremiumRatingsCautious Hold Rating for aTyr Pharma Amid Mixed Clinical Trial Results and Regulatory Uncertainty
5M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
5M ago
aTyr Pharma reports clinical benefit for efzofitimod across multiple diseases
Premium
The Fly
aTyr Pharma reports clinical benefit for efzofitimod across multiple diseases
5M ago
Wells Fargo downgrades aTyr Pharma on efzofitimod Phase 3 failure
PremiumThe FlyWells Fargo downgrades aTyr Pharma on efzofitimod Phase 3 failure
5M ago
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
5M ago
aTyr Pharma downgraded to Equal Weight from Overweight at Wells Fargo
Premium
The Fly
aTyr Pharma downgraded to Equal Weight from Overweight at Wells Fargo
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100